Log in

OTCMKTS:BGMD - BG Medicine Stock Price, Forecast & News

$0.02
-0.01 (-33.33 %)
(As of 02/27/2020 09:09 AM ET)
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.02
$0.03
52-Week Range
$0.01
Now: $0.02
$0.03
Volume836 shs
Average Volume3,511 shs
Market Capitalization$227,400.00
P/E RatioN/A
Dividend YieldN/A
Beta1.9
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolOTCMKTS:BGMD
Previous SymbolNASDAQ:BGMD
CUSIP08861T10
Phone781-890-1199

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5
Market Cap$227,400.00
Next Earnings DateN/A
OptionableNot Optionable

Receive BGMD News and Ratings via Email

Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter.


BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions

What is BG Medicine's stock symbol?

BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD."

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) issued its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) EPS for the quarter. The medical research company earned $334 million during the quarter, compared to the consensus estimate of $695 million. View BG Medicine's Earnings History.

Has BG Medicine been receiving favorable news coverage?

Media coverage about BGMD stock has trended negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. BG Medicine earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for BG Medicine.

Who are some of BG Medicine's key competitors?

What other stocks do shareholders of BG Medicine own?

Who are BG Medicine's key executives?

BG Medicine's management team includes the folowing people:
  • Dr. Paul R. Sohmer, CEO, Pres & Director (Age 70)
  • Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 68)
  • Dr. Aram Adourian, Chief Scientific Officer (Age 49)

How do I buy shares of BG Medicine?

Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BG Medicine's stock price today?

One share of BGMD stock can currently be purchased for approximately $0.02.

How big of a company is BG Medicine?

BG Medicine has a market capitalization of $227,400.00. BG Medicine employs 5 workers across the globe.View Additional Information About BG Medicine.

What is BG Medicine's official website?

The official website for BG Medicine is http://www.bg-medicine.com/.

How can I contact BG Medicine?

BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected]


MarketBeat Community Rating for BG Medicine (OTCMKTS BGMD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe BGMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BGMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel